Meet David Lee, the visionary founder and CEO of Singular Wings Medical
2024-02-28 / GlobalBio & Investment
**#Meet#StartupCEOs**MeetDavidLee(李維中),thevisionaryfounderandCEOofSingularWingsMedical.Fromtheelectronicsindustrytoentrepreneurship,hemerges#healthcarewith#electronics,craftinginnovativesolutionsforme...
Merck's Keytruda Leads 2023 Sales!
2024-02-28 / GlobalBio & Investment
**Merck'sKeytrudaLeads2023Sales!**Merck'sKeytrudaemergesasthetop-sellingdrugof2023,amassinganimpressive$25billioninsales.MerckCFOCarolineLitchfieldattributesKeytruda'ssurgein2023torecentap...
TBMC partners with U.S. firm National Resilience, Inc. for advanced bioprocessing
2024-02-28 / GlobalBio & Investment
**ExcitingNews!TaiwanBio-ManufacturingCorporation(#TBMC),the‘biotechTSMC,’partnerswithU.S.firmNationalResilience,Inc.foradvancedbioprocessing.ChairmanMichelChu(瞿志豪)outlinesaglobalapproachf...
AnBogen Therapeutics hits a milestone: completes USD 12.5M Series A funding round!
2024-02-28 / GlobalBio & Investment
**AnBogenTherapeuticshitsamilestone:completesUSD12.5MSeriesAfundinground!**InastrategicmoveledbyCDIBCapitalInternationalCorporation,AnBogenTherapeuticsproudlyannouncesthesuccessfulclosureofitsSeriesAf...
Revolutionizing Antibiotics: Xtraordinary Discovery by NCHU team!
2024-02-28 / GlobalBio & Investment
*RevolutionizingAntibiotics:XtraordinaryDiscoverybyNationalChungHsingUniversity(#NCHU)team!**NCHUresearchersmadeagroundbreakingdiscoveryinantibioticdevelopment.Theyfoundanucleotidesignalingmoleculetha...
EirGenix, Inc. and Sartorius delves into critical aspects such as sterile filtration
2024-02-28 / GlobalBio & Investment
**MasteringQualityAssurance!**SartoriusTaiwanelevatesproductqualitythroughrobustfiltrationsystemtesting.RZLin,aSartoriusTechSpecialist,underscoresthecrucialroleofQualityRiskManagement(#QRM)inmaintaini...
Personal Genomics secures victory in the patent battle
2024-01-25 / GlobalBio & Investment
ExcitingNews!CongratulationstoPersonalGenomicsforsecuringvictoryinthepatentbattle!TheU.S.AppealsCourtdismissedPacificBiosciences'appealonJanuary9,upholdingtheoriginaldecisionbytheU.S.PatentTrialan...
Globalbio magazine volume 112
2024-01-25 / GlobalBio & Investment
Involume112,Globalbiomagazinedivesintothenutsandboltsofimplementinginnovativemedicaltech. Breakingthroughthebarriersfromresearchtoclinicaltrialsisjustthestart,buttherealchallengekicksinaftervalidation...
TFDA certified Jellox Biotech's 'MetaLite DX Digital Pathology Software' as SaMD
2024-01-25 / GlobalBio & Investment
BigkudostoJelloxBiotechforreachingasignificantregulatorymilestone!TFDAcertifiedtheir'MetaLiteDXDigitalPathologySoftware'as#SaMD(SoftwareasMedicalDevice)thismonth,markingitthefirstofflineusable...
The latest progress of ADC drug development in Taiwan
2024-01-25 / GlobalBio & Investment
Antibody-drugconjugates(ADCs)featurespecificityandpotentchemotherapy.Sincetheirbreakthroughintreatingsolidtumorsin2019,ADCshavebecomeahotspotforstrategicalliancesandacquisitionsamongpharmaceuticalcomp...
The latest progress of six Taiwanese CAR-T therapy developers
2024-01-25 / GlobalBio & Investment
GlobalCAR-Tdevelopmentisbustling!AlthoughTaiwanenteredtheCAR-Tfieldlateandfacedhurdleslikepatents,severalcompaniesaretargetingCAR-Tandtakingchallengestomeettheunmetneeds.Theirclinicaltrialsareexpected...
Bio Preventive Medicine Corp.'s DNlite-IVD103 granted TFDA approval
2024-01-25 / GlobalBio & Investment
"Bettersafethansorry."CongratulationstoBioPreventiveMedicineCorp.fortheirinnovativekidneydiseasetestkit,DNlite-IVD103,grantedTFDAapproval!Thisbreakthroughbenefitsdiabeticpatientsbypredicting...